Laura Dember, MD
Enriched profileProfessor of Medicine and Epidemiology, University of Pennsylvania [ORCID, current] · University of Pennsylvania
Laura Dember is Professor of Medicine and Epidemiology, University of Pennsylvania [ORCID, current] at University of Pennsylvania. OpenAlex indexes 324 publications with 13,259 citations (h-index 59); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Nephrology profiles in the findmyKOL directory.
Data verified 21 Oct 2026
Overview
Updated 23 Oct 2026
Laura Dember, M.D., is Professor of Medicine and Epidemiology, University of Pennsylvania [ORCID, current]. The public record shows 324 publications with 13,259 citations (h-index 59), centered on Dialysis and Renal Disease Management, Amyloidosis: Diagnosis, Treatment, Outcomes, Central Venous Catheters and Hemodialysis. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 7 companies, 6 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · Clinical journal of the American Society of Nephrology
- Top research focus: Dialysis and Renal Disease Management
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 133.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Transforming Hemodialysis-Related Vascular Access Education
Sponsor: University of Pennsylvania
- Symptom Monitoring in Hemodialysis
Sponsor: University of Pennsylvania
- HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Industry payments
Updated 23 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20257 payments$17,396openpaymentsdata.cms.gov ↗
- CSL BehringProgram year20253 payments$15,000openpaymentsdata.cms.gov ↗
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20244 payments$30,519openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.8%Angiotensin receptor blocker (ARB)27.2%Valsartan100%Part D<11 patientsThiazide-like diuretic25.9%Chlorthalidone100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
27.2%Vitamin D3 Analog27.2%Calcitriol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 23 Oct 2026
6 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Continuation of the Chronic Renal Insufficiency Cohort (CRIC)
University of Pennsylvania
FY2026$1,000,000U24DK060990 - A Hybrid Type 1 Effectiveness-Implementation Study of Education Strategies for Vascular Access Creation in Advanced Kidney Disease
Univ of North Carolina Chapel Hill
FY2026$660,297R01DK132367 - Continuation of the Chronic Renal Insufficiency Cohort (CRIC)
University of Pennsylvania
FY2025$1,117,743U24DK060990
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Approach to Quality Control Used for the HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis.
Clinical journal of the American Society of Nephrology
Article2026 - Steroidal versus Nonsteroidal Mineralocorticoid Receptor Antagonists in CKD.
Journal of the American Society of Nephrology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Stress Granule Assembly Is Mediated by Prion-like Aggregation of TIA-1Article996 citations2004
- 02Effect of Clopidogrel on Early Failure of Arteriovenous Fistulas for HemodialysisArticle827 citations2008
- 03
- 04
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/laura-dember-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nephrology.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajkdblog.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajkdblog.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →orcid.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Raquel Gur, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Paul Richardson, MD
Dana-Farber Cancer Institute
S Rajkumar, MD
Mayo Clinic
Meletios Dimopoulos, MD
National and Kapodistrian University of Athens